Dr. Anders Elias Hansen
DVM, PhD
Dr. Anders Hansen will be teaching at the Oncology specialisation programme within the fields of cell biology and hallmarks of cancer.
Dr. Anders Hansen has since 2013 worked as a researcher at DTU Nanotech, Centre for Nanomedicine and Theranostics, Technical University of Denmark and Cluster for Molecular Imaging, Copenhagen University, Denmark. Since 2015 he ahs been CEO at Vaccex Cancer Immunoradiotherapy I/S, Denmark
Background
PhD, University of Copenhagen, Faculty of Life Sciences and Dept. Radiation Oncology, Copenhagen University Hospital, Denmark 2011
Externships: National Cancer Institute,National Institute of Health, Bethesda, MD, USA, fall 2010.
Cand. Med. Vet. (DVM), The Royal Veterinary and Agricultural University, Denmark 2006.
Externships: Clinical rotation, Internal Medicine, University of Georgia College of Veterinary Medicine, Spring 2005.
Work Experience:
Department of Radiation Oncology, "The Finsen Center" Copenhagen University Hospital
Post Doc. Research Fellow, Feb. 2011 - Feb. 2013, Department of Radiation Oncology, "The Finsen Center" Copenhagen University Hospital
PhD Student, October 2007 - May 2011, Small Animal Hospital, Faculty of Life Sciences, University of Copenhagen
March 2009 - January 2010 Senior Veterinarian, Oncology services.
March 2007 - October 2007 Staff veterinarian. Section of Biomedicine, Division of Laboratory Animal Science and Welfare, Department of Veterinary Pathobiology, The Royal Veterinary and Agricultural University, Denmark
2002 - 2005 Student research assistant (Laboratory animal section).
29 peer reviewed publications, 1 book chapter, 5 patents.
Research areas include; advanced drug delivery for cancer therapy, immunotherapy and inflammatory/infectious disease, experimental and translational animal models, molecular imaging of cancer and inflammation.
Co-owner and co-founder of biotechs; MonTa Biosciences A/S (2017). Vaccex I/S (2015). RehydrAid ApS (2015).
Supervisor for 11 PhD students and several MSc and DVM master students.